title: Novel adjunctive treatment for cervical adhesion with cross-type nelaton catheter: a preliminary report and literature review.
abstract: OBJECTIVE
  Intrauterine adhesion remains a common complication post dilatation and curettage (D&C) in reproductive females. Internal cervical orifice adhesion (ICA) is also observed incidentally after D&C. Here, we introduce a novel adjunctive management for ICA with cross-type nelaton catheter.
  
  
  METHODS
  In this study, 20 patients suffering from amenorrhea and ICA after D&C were included. All individuals underwent flexible hysteroscopy to confirm their simple ICA statuses. All women accepted the insertion of simple cross-type nelaton catheter. Two weeks post insertion, the catheter was removed and a second-look hysteroscopy was performed. Three months post catheter removal, the menstruation statuses and the efficiency of nelaton catheter in preventing ICA were evaluated.
  
  
  RESULTS
  Nineteen patients had 3-month follow-up. Seventeen individuals (89.4%) had normal menstruation flow as well as the impact internal orifice of cervical canal. Only two patients (10.5%) had hypomenorrhea and fibrotic narrowing of the internal orifice of the cervix, which required resectoscopy to remove the internal cervical adhesions. All patients appeared the competence of endurance for these procedures.
  
  
  CONCLUSIONS
  The novel cross-type nelaton catheter is a simple, well tolerated, and highly effective method for the management of ICA after D&C.
authors: Department of Obstetrics and Gynecology, Lin Shin Hospital, Taichung, Taiwan.
authors: Jen-Ching
authors: JC
authors: Lin
authors: Yun-O
authors: YO
authors: Chen
authors: Chi-Chen
authors: CC
authors: Chang
authors: Yao-Yuan
authors: YY
authors: Hsieh
mesh_terms: D002404:Catheterization / Q000295:instrumentation* / Q000379:methods*; D020878:Device Removal / Q000379:methods; D004107:Dilatation and Curettage / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015907:Hysteroscopy / Q000379:methods; D011474:Prosthesis Design; D000267:Tissue Adhesions / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome; D002577:Uterine Cervical Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*